Cryab Gene Crystallin Alpha B is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Parameter | Value |
|-----------|-------|
| **Gene Symbol** | CRYAB |
| **Full Name** | Crystallin Alpha B |
| **Chromosomal Location** | 11q23.1 |
| **NCBI Gene ID** | 1410 |
| **OMIM** | 123590 |
| **Ensembl ID** | ENSG00000109846 |
| **UniProt ID** | P02511 |
| **Associated Diseases** | Alzheimer's Disease, Parkinson's Disease, ALS, Alexander Disease, Cataracts |
The CRYAB gene encodes αB-crystallin, a small heat shock protein (sHsp) that functions as a molecular chaperone. It is one of the most abundant proteins in the lens of the eye but is also expressed in many tissues including the brain, heart, and skeletal muscle.
CRYAB/αB-crystallin is a multifunctional small heat shock protein:
- Molecular chaperone: Prevents aggregation of damaged proteins
- Cytoskeletal stabilization: Binds to intermediate filaments (GFAP, vimentin)
- Anti-apoptotic activity: Inhibits caspase activation
- Zinc binding: Protects against oxidative stress
- ATP-independent chaperone: Works without ATP hydrolysis
αB-crystallin forms large oligomeric complexes (12-24 subunits) that can sequester damaged proteins.
- αB-crystallin colocalizes with tau tangles
- Compensatory upregulation in AD brain
- Potential to reduce Aβ and tau pathology
- Protects against α-synuclein aggregation
- Overexpression reduces dopaminergic neuron loss
- Linked to protein quality control in Lewy bodies
- Mutant SOD1 interacts with αB-crystallin
- Protects against TDP-43 aggregation
- Therapeutic potential for proteinopathies
¶ Alexander Disease
- GFAP mutations cause Alexander disease
- αB-crystallin is a genetic modifier
- Rosenthal fibers contain αB-crystallin
CRYAB is expressed in many tissues:
- Lens (very high)
- Heart, skeletal muscle
- Brain (neurons and glia)
In brain:
- Astrocytes (high expression)
- Oligodendrocytes
- Some neurons
- Particularly in white matter
αB-crystallin is a promising therapeutic target:
-
Protein Aggregation Diseases
- Direct delivery of αB-crystallin
- Small molecule inducers
-
Neuroprotection
- Anti-apoptotic strategies
- Cytoskeletal stabilization
-
Delivery Challenges
- Webster JM, et al. (2020). αB-crystallin in neurodegeneration. Cell 9(10):2197.
- Pasupuleti N, et al. (2010). αB-crystallin in oxidative stress. Cell Stress Chaperones 15(6):753-61.
- Ohto S, et al. (2006). αB-crystallin in ALS. Neurology 67(10):1773-7.
CRYAB is expressed in most tissues:
- High expression in lens, heart, and skeletal muscle
- Moderate expression in brain (astrocytes and neurons)
- Induced under stress conditions
In the brain:
- Expressed in astrocytes (higher than neurons)
- Upregulated in response to cellular stress
- Detected in cerebral cortex, hippocampus, cerebellum
- Cryab knockout mice show cataracts
- Transgenic mice overexpressing mutant CRYAB show neuroprotection
- Drosophila models reveal chaperone function in neurons
- Small heat shock protein therapeutics
- Chaperone-based therapies for protein aggregation diseases
- Understanding sHsp oligomer dynamics
- Biomarker potential in neurodegenerative diseases
The study of Cryab Gene Crystallin Alpha B has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.